These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23884910)

  • 21. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
    Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.
    Chai S; Xu X; Wang Y; Zhou Y; Zhang C; Yang Y; Yang Y; Xu H; Xu R; Wang K
    Oncotarget; 2015 Jun; 6(18):16069-83. PubMed ID: 25965829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation regulates AKT1 activity.
    de la Cruz-Herrera CF; Campagna M; Lang V; del Carmen González-Santamaría J; Marcos-Villar L; Rodríguez MS; Vidal A; Collado M; Rivas C
    Oncogene; 2015 Mar; 34(11):1442-50. PubMed ID: 24704831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
    Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
    Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.
    Belaguli NS; Zhang M; Brunicardi FC; Berger DH
    PLoS One; 2012; 7(10):e48019. PubMed ID: 23118920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
    Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
    Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.
    Sun L; Li H; Chen J; Dehennaut V; Zhao Y; Yang Y; Iwasaki Y; Kahn-Perles B; Leprince D; Chen Q; Shen A; Xu Y
    J Natl Cancer Inst; 2013 Jun; 105(12):887-98. PubMed ID: 23704280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein inhibitor of activated STAT1 Ser
    Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
    Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
    Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
    Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
    Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
    Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle.
    Risso G; Pelisch F; Pozzi B; Mammi P; Blaustein M; Colman-Lerner A; Srebrow A
    Cell Cycle; 2013 Oct; 12(19):3165-74. PubMed ID: 24013425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant AKT1-E17K is oncogenic in lung epithelial cells.
    De Marco C; Malanga D; Rinaldo N; De Vita F; Scrima M; Lovisa S; Fabris L; Carriero MV; Franco R; Rizzuto A; Baldassarre G; Viglietto G
    Oncotarget; 2015 Nov; 6(37):39634-50. PubMed ID: 26053093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.